Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
3.

Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding.

Mita H, Tsutsui J, Takekawa M, Witten EA, Saito H.

Mol Cell Biol. 2002 Jul;22(13):4544-55.

4.

gadd45 is not required for activation of c-Jun N-terminal kinase or p38 during acute stress.

Wang X, Gorospe M, Holbrook NJ.

J Biol Chem. 1999 Oct 15;274(42):29599-602.

5.

MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta.

Abell AN, Granger DA, Johnson GL.

J Biol Chem. 2007 Oct 19;282(42):30476-84. Epub 2007 Aug 28.

6.

Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3.

Du Y, Böck BC, Schachter KA, Chao M, Gallo KA.

J Biol Chem. 2005 Dec 30;280(52):42984-93. Epub 2005 Oct 27.

7.

c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.

Repici M, Mare L, Colombo A, Ploia C, Sclip A, Bonny C, Nicod P, Salmona M, Borsello T.

Neuroscience. 2009 Mar 3;159(1):94-103. doi: 10.1016/j.neuroscience.2008.11.049. Epub 2008 Dec 14.

PMID:
19135136
8.
10.
11.

The Ser(186) phospho-acceptor site within ERK4 is essential for its ability to interact with and activate PRAK/MK5.

Perander M, Aberg E, Johansen B, Dreyer B, Guldvik IJ, Outzen H, Keyse SM, Seternes OM.

Biochem J. 2008 May 1;411(3):613-22. doi: 10.1042/BJ20071369.

PMID:
18248330
12.

Dimerization through the catalytic domain is essential for MEKK2 activation.

Cheng J, Yu L, Zhang D, Huang Q, Spencer D, Su B.

J Biol Chem. 2005 Apr 8;280(14):13477-82. Epub 2005 Feb 4.

13.

ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.

Barsyte-Lovejoy D, Galanis A, Clancy A, Sharrocks AD.

Biochem J. 2004 Aug 1;381(Pt 3):693-9.

14.

CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway.

Aissouni Y, Zapart G, Iovanna JL, Dikic I, Soubeyran P.

Biochem Biophys Res Commun. 2005 Dec 16;338(2):808-14. Epub 2005 Oct 18.

PMID:
16256071
15.

A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.

Pirruccello M, Sondermann H, Pelton JG, Pellicena P, Hoelz A, Chernoff J, Wemmer DE, Kuriyan J.

J Mol Biol. 2006 Aug 11;361(2):312-26. Epub 2006 Jun 27.

PMID:
16837009
16.

N-terminus-mediated dimerization of ROCK-I is required for RhoE binding and actin reorganization.

Garg R, Riento K, Keep N, Morris JD, Ridley AJ.

Biochem J. 2008 Apr 15;411(2):407-14. doi: 10.1042/BJ20071342.

PMID:
18215121
17.

The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity.

Goto S, Yao Z, Proud CG.

Biochem J. 2009 Sep 25;423(2):279-90. doi: 10.1042/BJ20090228.

PMID:
19650764
18.

The signalling profile of recombinant human orexin-2 receptor.

Tang J, Chen J, Ramanjaneya M, Punn A, Conner AC, Randeva HS.

Cell Signal. 2008 Sep;20(9):1651-61. doi: 10.1016/j.cellsig.2008.05.010. Epub 2008 May 27.

PMID:
18599270
19.

Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.

Thiel KW, Carpenter G.

Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19238-43. Epub 2007 Nov 27.

20.

Supplemental Content

Support Center